Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
General Rheumatology
•
JAK Inhibitors
•
Gastroenterology
•
Dermatology
•
Nephrology
Have you utilized JAK inhibitors in patients on dialysis?
Related Questions
What is your approach to management of hyperlipidemia in patients taking JAK inhibitors?
How do you counsel patients who experience diarrhea from mycophenolate mofetil (Cellcept)?
What is your approach to using topical JAK inhibitors in the management of cutaneous manifestations of rheumatic disease?
How do you approach managing nausea and GI side effects when initiating methotrexate?
What is your approach to treatment in patients with cutaneous mastocytosis and inflammatory arthritis?
Can Dupixent (dupliumab) be safely used in patients who are taking other biologics for rheumatic disease?
Do you recommend sending an autoimmune work up for patients with recurrent nephrolithiasis and 24 hour urine chemistries consistent with distal renal tubular acidosis?
How do you counsel and manage joint pain after isotretinoin treatment?
What therapies have you found most effective for JAK-induced/associated acne (JAKcne)?
Would you switch azathioprine to a different immunosuppressant if a controlled patient with SLE develops melanoma and/or non-melanoma skin cancer?
